Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study
Title:
Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II study
Author:
Fuereder, Thorsten Minichsdorfer, Christoph Mittlboeck, Martina Wagner, Christina Heller, Gerwin Putz, Eva M. Oberndorfer, Felicitas Müllauer, Leonhard Aretin, Marie-Bernadette Czerny, Christian Schwarz-Nemec, Ursula